AAAAAA

   
Results: 1-3 |
Results: 3
Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding
Authors: Kitchen, D Smith, D
Citation: D. Kitchen et D. Smith, Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding, SEIZURE-E J, 10(4), 2001, pp. 265-268
Molecular modeling of the aldose reductase-inhibitor complex based on the X-ray crystal structure and studies with single-site-directed mutants
Authors: Singh, SB Malamas, MS Hohman, TC Nilakantan, R Carper, DA Kitchen, D
Citation: Sb. Singh et al., Molecular modeling of the aldose reductase-inhibitor complex based on the X-ray crystal structure and studies with single-site-directed mutants, J MED CHEM, 43(6), 2000, pp. 1062-1070
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)
Authors: Discafani, CM Carroll, ML Floyd, MB Hollander, IJ Husain, Z Johnson, BD Kitchen, D May, MK Malo, MS Minnick, AA Nilakantan, R Shen, R Wang, YF Wissner, A Greenberger, LM
Citation: Cm. Discafani et al., Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785), BIOCH PHARM, 57(8), 1999, pp. 917-925
Risultati: 1-3 |